RPRX- Royalty Pharma Plc

Name: Royalty Pharma Plc Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Royalty Pharma Plc (RPRX) has 15 insiders with recent SEC Form 4 filings, including 1 buy and 28 sells. RPRX is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Legorreta Pablo G.	941.0K	$47.79M	-
VP	Hite Christopher	658.5K	$33.45M	-
Dir	Norden Gregory	194.8K	$9.90M	-
Dir	Desouza Errol B	81.4K	$4.13M	-
?	Bassler Bonnie L	73.1K	$3.71M	-

Activity

Buys and sells only

Transactions

10 filings · page 8

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
May 16, 2022	Urist Marshall73	EVP, Research &Investments	Sell	23,333	$39.85	$929,836.38	-33.3%	+9.6%	-16.3%
Mar 29, 2022	Riggs Rory B67	Director	Sell	60,000	$38.59	$2,315,322.00	-9.1%	+11.1%	-4.4%
Mar 21, 2022	Riggs Rory B67	Director	Sell	169,089	$39.43	$6,667,520.87	-57.5%	+3.4%	-8.5%
Feb 24, 2022	Fernandez Henry A48	Director	Buy	32,500	$37.49	$1,218,373.00	+126.5%	+6.7%	-2.7%
Dec 29, 2021	Riggs Rory B67	Director	Sell	184,448	$40.12	$7,400,767.20	-6.4%	-2.6%	+0.8%
Nov 17, 2021	Riggs Rory B67	Director	Sell	214,389	$42.34	$9,076,491.96	-4.3%	-4.7%	+1.9%
Nov 17, 2021	Lloyd George W.71	EVP, Investments &GC	Sell	250,000	$42.39	$10,596,693.28	-9.6%	-4.7%	+1.9%
Sep 29, 2021	Riggs Rory B67	Director	Sell	128,425	$36.51	$4,688,288.01	-1.6%	+10.4%	+11.9%
Jul 26, 2021	Lloyd George W.71	EVP, Investments &GC	Sell	13,362	$39.78	$531,532.49	-1.0%	-4.7%	+10.3%
Jul 26, 2021	Reddoch James F.66	EVP, Research &Investments	Sell	8,949	$39.78	$355,976.90	-0.8%	-4.7%	+10.3%

← PrevPage 8Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC